pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
Alecensa 150 mg hard capsules
Approved · small molecule · ALK positive non-small cell lung cancer
Alecensa 150 mg hard capsules for ALK positive non-small cell lung cancer is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Internal code NL77596.042.21
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Approved
- Modality
- small_molecule
- Indication
- ALK positive non-small cell lung cancer
- Status
- active
- Trials
- 1